More vaccines enter Phase III trials, researchers are learning more about the long-term impact of Covid-19, and risk calculation becomes increasingly difficult as the country reopens – Tech in Two.



Sleep timer



You are now using the open player. If you log in and subscribe to the podcast, Cloud Caster will keep track on your playlist and the position you paused an episode so you can resume it on any computer or phone.

Advertisment: